Most Researched Peptides in 2026 — A UK Laboratory Guide
The peptide research landscape has expanded rapidly. From GLP-1 analogues to collagen-modulating peptides, 2026 has seen record levels of academic and institutional interest in synthetic peptide compounds. This guide profiles the most actively studied compounds currently available for UK laboratory research.
Contents
1. BPC-157 — Body Protection Compound
BPC-157 remains one of the most extensively researched synthetic peptides globally. A 15-amino-acid fragment derived from human gastric juice, it has been the subject of over 80 peer-reviewed publications examining its interactions with the nitric oxide system, growth factor pathways, and gastrointestinal cell line models.
UK research interest in BPC-157 has grown significantly since 2023, with increased academic focus on fibroblast cell culture studies and vascular endothelial models. Available as a 10mg lyophilised vial, HPLC-verified at ≥98% purity.
→ View BPC-157 Research Profile2. Retatrutide — Triple Agonist Research
Retatrutide (LY3437943) is a tri-agonist peptide that activates GLP-1, GIP, and glucagon receptors simultaneously. It is among the most intensively studied compounds in metabolic research, with Phase 3 clinical trial data published by Eli Lilly showing exceptional results in academic models of adiposity and glucose regulation.
For in-vitro laboratory researchers studying metabolic receptor biology and energy homeostasis pathways, Retatrutide represents one of the most relevant and contemporary compounds available in 2026. Available as 10mg lyophilised vials.
→ View Retatrutide Research Profile3. Semaglutide — GLP-1 Receptor Agonist Research
Semaglutide is a long-acting GLP-1 receptor agonist originally developed as a pharmaceutical compound. Its research analogue is one of the most widely studied peptides in in-vitro metabolic research globally, with thousands of published papers examining receptor binding kinetics, beta-cell studies, and neurological signalling models.
Research-grade semaglutide enables UK laboratory professionals to conduct receptor binding assays and downstream signalling studies using a structurally identical reference compound. Available in 10mg lyophilised form at ≥98% purity.
→ View Semaglutide Research Profile4. GHK-Cu — Copper Tripeptide Research
GHK-Cu (Glycine-Histidine-Lysine Copper) is a naturally occurring copper-binding tripeptide found in human plasma. It has been the subject of extensive research in dermatology, wound healing biology, and gene expression studies. Researchers have identified interactions with over 4,000 human genes in published microarray studies.
Its role in collagen synthesis, antioxidant enzyme upregulation, and anti-inflammatory pathways in cell cultures makes it one of the most multifaceted compounds in current peptide research. Available in 100mg lyophilised vials.
→ View GHK-Cu Research Profile5. NAD+ — Nicotinamide Adenine Dinucleotide
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme central to mitochondrial function and cellular energy metabolism. It is one of the most widely researched molecules in the field of geroscience, with published studies examining its role in sirtuin activation, DNA repair pathways, and cellular senescence in vitro.
The rapid decline of NAD+ in ageing cell models has made it a cornerstone of longevity and metabolic research. Laboratory-grade NAD+ is available in high-concentration 500mg lyophilised vials suitable for cell culture supplementation studies.
→ View NAD+ Research Profile6. Melanotan II — Melanocortin Receptor Research
Melanotan II is a cyclic synthetic analogue of α-MSH (alpha-melanocyte stimulating hormone). It binds with high affinity to melanocortin receptors (MC1R through MC5R) and has been extensively used in laboratory research examining pigmentation signalling, melanogenesis, and neuroendocrine pathways.
Published in-vitro research using Melanotan II has examined melanocyte cell activation, cAMP signalling cascades, and receptor selectivity profiles across melanocortin receptor subtypes. Available as 10mg lyophilised vials.
→ View Melanotan II Research Profile7. Ipamorelin — Selective GHRP Research
Ipamorelin is a highly selective growth hormone releasing peptide (GHRP) and ghrelin receptor agonist. Unlike earlier GHRPs, its research profile shows a high degree of selectivity for GH release pathways without significant interaction with cortisol or prolactin pathways in cell model studies — making it a clean tool for studying the ghrelin receptor axis.
It is frequently studied alongside CJC-1295 in laboratory settings examining pituitary and hypothalamic signalling models. Available as 5mg lyophilised vials at ≥98% purity.
→ View Ipamorelin Research ProfileChoosing the Right Compound for Your Research
Selecting a research peptide depends on the biological pathway or cell model under investigation. Below is a quick reference:
- Gastrointestinal / wound biology cell models: BPC-157
- Metabolic receptor binding studies: Retatrutide, Semaglutide
- Collagen / dermal fibroblast studies: GHK-Cu
- Mitochondrial / senescence models: NAD+
- Melanocortin receptor studies: Melanotan II, Selank
- GH axis / pituitary models: Ipamorelin, CJC-1295 DAC
- Nootropic / anxiolytic cell models: Semax, Selank
Shop Research-Grade Peptides — UK Stock
12 compounds · HPLC ≥98% · Lyophilised vials · COA on request · Royal Mail tracked dispatch
Browse All Compounds →